<VariationArchive VariationID="1420974" VariationName="NC_000006.11:g.(?_74325018)_(74325190_?)del" VariationType="Deletion" Accession="VCV001420974" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1399701" VariationID="1420974">
      <GeneList>
        <Gene Symbol="SLC17A5" FullName="solute carrier family 17 member 5" GeneID="26503" HGNC_ID="HGNC:10933" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="73593379" stop="73653992" display_start="73593379" display_stop="73653992" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="74303101" stop="74363736" display_start="74303101" display_stop="74363736" Strand="-" />
          </Location>
          <OMIM>604322</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000006.11:g.(?_74325018)_(74325190_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6q13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" innerStart="74325018" innerStop="74325190" display_start="74325018" display_stop="74325190" variantLength="173" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.(?_74325018)_(74325190_?)del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.(?_74325018)_(74325190_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000006.11:g.(?_74325018)_(74325190_?)del AND Salla disease" Accession="RCV001916699" Version="5">
        <ClassifiedConditionList TraitSetID="1581">
          <ClassifiedCondition DB="MedGen" ID="C1096903">Salla disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-11" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10581036</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10947946</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15172001</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1581" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4393" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Salla disease</ElementValue>
                <XRef ID="MONDO:0011449" DB="MONDO" />
                <XRef ID="87074006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sialuria, Finnish type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">N-acetylneuraminic acid (NANA) storage disease (NSD)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Infantile sialic acid storage disorder (ISSD)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Free Sialic Acid Storage Disorders</ElementValue>
                <XRef ID="NBK1470" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SD</ElementValue>
                <XRef Type="MIM" ID="604369" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4754" />
                <XRef ID="4754" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Free sialic acid storage disorders (FSASDs) are a spectrum of neurodegenerative disorders resulting from increased lysosomal storage of free sialic acid. Historically, FSASD was divided into separate allelic disorders: Salla disease, intermediate severe Salla disease, and infantile free sialic acid storage disease (ISSD). The mildest type was Salla disease, characterized by normal appearance and absence of neurologic findings at birth, followed by slowly progressive neurologic deterioration resulting in mild-to-moderate psychomotor delays, spasticity, athetosis, and epileptic seizures. Salla disease was named for a municipality in Finnish Lapland where a specific founder variant is relatively prevalent. However, the term Salla has been used in the literature to refer to less severe FSASD. More severe FSASD is historically referred to as ISSD, and is characterized by severe developmental delay, coarse facial features, hepatosplenomegaly, and cardiomegaly; death usually occurs in early childhood.</Attribute>
                <XRef ID="NBK1470" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301643</ID>
                <ID Source="BookShelf">NBK1470</ID>
              </Citation>
              <XRef ID="309334" DB="Orphanet" />
              <XRef ID="834" DB="Orphanet" />
              <XRef ID="C1096903" DB="MedGen" />
              <XRef ID="MONDO:0011449" DB="MONDO" />
              <XRef Type="MIM" ID="604369" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4210295" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_012434.4_6_Deletion (exon 8)|MedGen:C1096903" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002188620" DateUpdated="2024-06-09" DateCreated="2022-03-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10581036</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10947946</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15172001</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 8 of the SLC17A5 gene. This deletion is out-of-frame, and is expected to create a premature termination codon and result in an absent or disrupted protein product. Loss-of-function variants in SLC17A5 are known to be pathogenic (PMID: 10581036, 10947946, 15172001). This variant has not been reported in the literature in individuals affected with SLC17A5-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC17A5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.(?_74325018)_(74325190_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1096903" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4210295" TraitType="Disease" MappingType="XRef" MappingValue="C1096903" MappingRef="MedGen">
        <MedGen CUI="C1096903" Name="Salla disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

